ArticleMicrocirculation (New York, N.Y. : 1994)2020

BCR-ABL tyrosine kinase inhibitors promote pathological changes in dilator phenotype in the human microvasculature.

Matthew J Durand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.